These findings highlight the potential role of CD69 in promoting AML cell survival and malignant proliferation, further supporting the role of CD69 in regulating cell survival and highlighting its potential as a therapeutic target in AML. This evidence concerns the gene CD69 and acute myeloid leukemia.